• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Melaena following Use of the Cholinesterase Inhibitor Rivastigmine.

作者信息

Gareri Pietro, Gallelli Luca, Ferreri Ibbadu Guido, Lacava Roberto, Russo Emilio, De Sarro Giovambattista

机构信息

Clinical Pharmacology Unit, Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Regional Pharmacovigilance Center, Mater Domini University Hospital, Catanzaro, ItalyOperative Unit ‘Elderly Health Care’, Catanzaro, Italy.

出版信息

Clin Drug Investig. 2005;25(3):215-7. doi: 10.2165/00044011-200525030-00008.

DOI:10.2165/00044011-200525030-00008
PMID:17523771
Abstract
摘要

相似文献

1
Melaena following Use of the Cholinesterase Inhibitor Rivastigmine.
Clin Drug Investig. 2005;25(3):215-7. doi: 10.2165/00044011-200525030-00008.
2
Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine.使用卡巴拉汀治疗的阿尔茨海默病患者使用抗精神病药物的风险。
Drugs Aging. 2004;21(6):395-403. doi: 10.2165/00002512-200421060-00004.
3
Drug persistency of two cholinesterase inhibitors: rivastigmine versus donepezil in elderly patients with Alzheimer's disease.两种胆碱酯酶抑制剂的药物持续作用：卡巴拉汀与多奈哌齐在老年阿尔茨海默病患者中的比较
Drugs Aging. 2005;22(8):695-707. doi: 10.2165/00002512-200522080-00006.
4
Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.胆碱酯酶抑制剂治疗阿尔茨海默病：耐受性与药理学比较
Drug Saf. 1998 Dec;19(6):465-80. doi: 10.2165/00002018-199819060-00004.
5
Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.胆碱酯酶抑制剂的临床药代动力学和药效学
Clin Pharmacokinet. 2002;41(10):719-39. doi: 10.2165/00003088-200241100-00003.
6
Influence of cholinesterase inhibitors, donepezil and rivastigmine on the acquisition, expression, and reinstatement of morphine-induced conditioned place preference in rats.胆碱酯酶抑制剂多奈哌齐和卡巴拉汀对大鼠吗啡诱导的条件性位置偏爱形成、表达及恢复的影响。
Behav Brain Res. 2014 Jul 15;268:169-76. doi: 10.1016/j.bbr.2014.04.019. Epub 2014 Apr 19.
7
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.两年期里，卡巴拉汀与多奈哌齐治疗中度至中度重度阿尔茨海默病。
Curr Med Res Opin. 2005 Aug;21(8):1317-27. doi: 10.1185/030079905X56565.
8
Risk of pneumonia in new users of cholinesterase inhibitors for dementia.痴呆症胆碱酯酶抑制剂新使用者患肺炎的风险。
J Am Geriatr Soc. 2015 May;63(5):869-76. doi: 10.1111/jgs.13380. Epub 2015 Apr 27.
9
Two cholinesterase inhibitors trigger dissimilar effects on behavior and body weight in C57BL/6 mice: The case of chlorpyrifos and rivastigmine.
Behav Brain Res. 2017 Feb 1;318:1-11. doi: 10.1016/j.bbr.2016.10.014. Epub 2016 Oct 11.
10
Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.卡巴拉汀对阿尔茨海默病患者脑脊液中乙酰胆碱酯酶和丁酰胆碱酯酶的抑制作用：与认知改善的相关性
J Neural Transm (Vienna). 2002 Jul;109(7-8):1053-65. doi: 10.1007/s007020200089.

引用本文的文献

1
Acetylcholine Inhibits Platelet Activation.乙酰胆碱抑制血小板活化。
J Pharmacol Exp Ther. 2019 May;369(2):182-187. doi: 10.1124/jpet.118.253583. Epub 2019 Feb 14.
2
The CITIRIVAD Study: CITIcoline plus RIVAstigmine in Elderly Patients Affected with Dementia Study.西替立明联合卡巴拉汀治疗老年痴呆症的研究：CITIRIVAD研究
Clin Drug Investig. 2016 Dec;36(12):1059-1065. doi: 10.1007/s40261-016-0454-3.
3
Effects of phenobarbital and levetiracetam on PR and QTc intervals in patients with post-stroke seizure.苯巴比妥和左乙拉西坦对脑卒中后癫痫患者PR间期和QTc间期的影响。

本文引用的文献

1
[Vagotomy in the treatment of bleeding reflux-esophagitis and gastroduodenal bleedings].
Khirurgiia (Mosk). 2004(6):24-6.
2
[Tolerance and adverse events of treatment with acetylcholinesterase inhibitors in a clinical sample of patients with very slight and mild Alzheimer s disease over a six-month period].[在一个非常轻度和轻度阿尔茨海默病患者临床样本中，乙酰胆碱酯酶抑制剂治疗六个月期间的耐受性和不良事件]
Rev Neurol. 2003;36(5):421-4.
3
Cell biology of acid secretion by the parietal cell.壁细胞泌酸的细胞生物学
Clin Drug Investig. 2014 Dec;34(12):879-86. doi: 10.1007/s40261-014-0243-9.
4
Effects of glucocorticoids and tumor necrosis factor-alpha inhibitors on both clinical and molecular parameters in patients with Takayasu arteritis.糖皮质激素和肿瘤坏死因子-α抑制剂对大动脉炎患者临床及分子参数的影响。
J Pharmacol Pharmacother. 2014 Jul;5(3):193-6. doi: 10.4103/0976-500X.136101.
5
Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis.低剂量甲氨蝶呤与类风湿关节炎治疗用药之间的相互作用。
Adv Pharmacol Sci. 2013;2013:313858. doi: 10.1155/2013/313858. Epub 2013 May 12.
6
Somatic comorbidities and Alzheimer's disease treatment.躯体共病与阿尔茨海默病治疗。
Neurol Sci. 2013 Sep;34(9):1581-9. doi: 10.1007/s10072-013-1290-3. Epub 2013 Feb 1.
Annu Rev Physiol. 2003;65:103-31. doi: 10.1146/annurev.physiol.65.072302.114200. Epub 2002 Aug 5.
4
The tolerability and safety of cholinesterase inhibitors in the treatment of dementia.胆碱酯酶抑制剂治疗痴呆症的耐受性和安全性。
Int J Clin Pract Suppl. 2002 Jun(127):45-63.
5
Rivastigmine in outpatient services: experience of 114 neurologists in Austria.门诊服务中使用的卡巴拉汀：奥地利114位神经科医生的经验
Int Clin Psychopharmacol. 2002 Mar;17(2):81-5. doi: 10.1097/00004850-200203000-00007.
6
An open-label study to evaluate the safety, tolerability and efficacy of rivastigmine in patients with mild to moderate probable Alzheimer's disease in the community setting.一项开放标签研究，旨在评估卡巴拉汀在社区环境中轻度至中度可能患有阿尔茨海默病患者中的安全性、耐受性和疗效。
Med Sci Monit. 2002 Feb;8(2):PI9-15.
7
The stomach divalent ion-sensing receptor scar is a modulator of gastric acid secretion.胃二价离子感应受体瘢痕是胃酸分泌的调节剂。
J Biol Chem. 2001 Oct 26;276(43):39549-52. doi: 10.1074/jbc.M107315200. Epub 2001 Aug 15.
8
Review of rivastigmine and its clinical applications in Alzheimer's disease and related disorders.卡巴拉汀及其在阿尔茨海默病和相关疾病中的临床应用综述。
Expert Opin Pharmacother. 2001 Apr;2(4):653-66. doi: 10.1517/14656566.2.4.653.
9
Gastroprotective agents for the prevention of NSAID-induced gastropathy.用于预防非甾体抗炎药引起的胃病的胃保护剂。
Curr Pharm Des. 1998 Feb;4(1):17-36.
10
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.卡巴拉汀治疗阿尔茨海默病患者的疗效和安全性：国际随机对照试验。
BMJ. 1999 Mar 6;318(7184):633-8. doi: 10.1136/bmj.318.7184.633.